We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 9 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 5 actions collected · 5 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 01. 16. | UBS | — | Downgrade | Buy → Neutral | — | UBS: Buy → Neutral |
| 2026. 01. 07. | Barclays | — | Downgrade | Overweight → Equal-Weight | — | Barclays: Overweight → Equal-Weight |
| 2025. 12. 09. | Guggenheim | — | Downgrade | Buy → Neutral | — | Guggenheim: Buy → Neutral |
| 2025. 12. 08. | JP Morgan | — | Downgrade | Overweight → Neutral | — | JP Morgan: Overweight → Neutral |
| 2025. 09. 08. | Morgan Stanley | — | Upgrade | Equal-Weight → Overweight | — | Morgan Stanley: Equal-Weight → Overweight |
Past rating changes by firm, agreement/divergence within the sector, and what target changes mean.